Abstract | OBJECTIVE: METHODS: This was an open-label, parallel-group, 1:1:1 randomized study of adults with type 2 diabetes mellitus on oral antidiabetic drugs with glycated hemoglobin (A1C) levels of 8.0% or greater. After a 14-week run-in with insulin glargine, patients with an A1C level greater than 7.0% were randomly assigned to 1, 2, or 3 time(s) daily insulin glulisine for 24 weeks. Changes in A1C from randomization to study end; percentage of patients achieving an A1C level less than 7.0%; changes in A1C, fasting glucose concentrations, and weight at individual study points; and safety (adverse events and hypoglycemia) were assessed throughout the study. RESULTS: Three hundred forty-three of 631 patients (54%) completing the run-in phase with insulin glargine were randomly assigned to treatment arms. During the randomization phase, A1C reductions with insulin glulisine once or twice daily were noninferior to insulin glulisine 3 times daily (confidence intervals: -0.39 to 0.36 and -0.30 to 0.43; P>.5 for both). However, more patients met the target A1C with 3 preprandial injections (46 [46%]) than with 2 injections (34 [33%]) or 1 injection (30 [30%]). Severe hypoglycemia occurred in twice as many patients receiving 3 preprandial injections (16%) compared with those receiving 2 injections (8%) and 1 injection (7%), but these differences did not reach significance. CONCLUSION: This study provides evidence that initiation of prandial insulin in a simplified stepwise approach is an effective alternative to the current routine 3 preprandial injection basal-bolus approach.
|
Authors | Mayer B Davidson, Philip Raskin, Robert J Tanenberg, Aleksandra Vlajnic, Pricilla Hollander |
Journal | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
(Endocr Pract)
2011 May-Jun
Vol. 17
Issue 3
Pg. 395-403
ISSN: 1934-2403 [Electronic] United States |
PMID | 21324825
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Glycated Hemoglobin A
- Hypoglycemic Agents
- Insulin
- Insulin, Long-Acting
- hemoglobin A1c protein, human
- insulin glulisine
|
Topics |
- Adolescent
- Adult
- Aged
- Algorithms
- Blood Glucose
(drug effects, metabolism)
- Diabetes Mellitus, Type 2
(blood, drug therapy)
- Drug Administration Schedule
- Female
- Glycated Hemoglobin
(analysis)
- Humans
- Hypoglycemic Agents
(administration & dosage, adverse effects, therapeutic use)
- Insulin
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Insulin, Long-Acting
- Male
- Middle Aged
- Treatment Failure
- Young Adult
|